'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. - Wikidata - awgldk - TriplyDB

'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

http://www.wikidata.org/entity/Q49017127

about

Surgical decompression for cerebral oedema in acute ischaemic stroke Rodent models of focal stroke: size, mechanism, and purpose Managing malignant cerebral infarction Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat The proteome of human brain microdialysate Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke Clinical MRI of acute ischemic stroke Critical care for patients with massive ischemic stroke Intracranial pressure elevation reduces flow through collateral vessels and the penetrating arterioles they supply. A possible explanation for 'collateral failure' and infarct expansion after ischemic stroke.Novel treatment targets for cerebral edema Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study Glyburide is associated with attenuated vasogenic edema in stroke patients.Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications.Surgical decompression for cerebral oedema in acute ischaemic stroke.Aquaporin-4 autoantibodies increase vasogenic edema formation and infarct size in a rat stroke model Human Data Supporting Glyburide in Ischemic Stroke.The Role of Vascular Imaging in the Initial Assessment of Patients with Acute Ischemic Stroke.Effect of osmotherapy with hypertonic saline on regional cerebral edema following experimental stroke: a study utilizing magnetic resonance imaging.Detrimental effects of tropisetron on permanent ischemic stroke in the rat.Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.Patient outcomes in historical comparators compared with randomised-controlled trials.Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke.Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial.Stroke in childhood.Vascular pathology in the aged human brain Pretreatment with a novel aquaporin 4 inhibitor, TGN-020, significantly reduces ischemic cerebral edema.Cerebral ischemia-reperfusion injury in rats--a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation.Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials.A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?Aggressive care after a massive stroke in young patients: is that what they want?Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury.Health state preferences and decision-making after malignant middle cerebral artery infarctions European Stroke Initiative (EUSI) recommendations for stroke management. The European Stroke Initiative Writing Committee.Update on acute endovascular and surgical stroke treatment.Is decompressive craniectomy for malignant middle cerebral artery infarction of any worth?DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry (DESTINY-R): design and protocols.Zingiber officinale Mitigates Brain Damage and Improves Memory Impairment in Focal Cerebral Ischemic Rat.Cerebrovascular complications in pediatric intensive care unit.

P2860

Q24203893-D8EED2FC-13B3-4197-A97A-29D55CCD00C4 Q24529165-C9F0F4BA-36BE-4A2F-99A8-E09C2534D7EF Q24623989-C38B7053-E443-456B-BA18-A412CCE13A82 Q24796019-FB859FC1-84D2-45C2-8E4B-14949C44BB9E Q24806454-486B6D62-88A7-471F-8839-EB2334F675E6 Q26765300-99517016-5F57-47B5-BB42-166652D63AA7 Q26766038-CBA57347-5B60-43BD-A984-0E4F8747F2ED Q26865572-7CF73F61-36D4-46E2-A9BF-76B4C11AF5F9 Q27025932-4DD7BAD6-FA12-4D67-81E5-18F1104D1E23 Q27321358-33F1EB59-037F-4F0C-B462-69C68EF459D8 Q28254203-80DA89BD-8BAF-470C-9BCF-E8C65FB937A5 Q30495153-DB7C9B57-1A0B-4163-A02A-3E586B5D61B1 Q30570937-CA9A6AD6-3180-4EB6-AF1A-01AACF005AAC Q30670386-831F0A6B-9411-4468-882F-28F45595DFF4 Q30833640-FD75B9EC-9FD4-4F4C-A350-939661BF87A2 Q30838905-484CC343-FBFB-4487-8242-48D11FE51028 Q30953714-395E56C6-A055-49A2-9E1E-37E1D74AC57A Q31004806-A628E5E4-9321-483D-8A95-96EB34DB1779 Q31048044-76C45848-3ECD-47A4-B93C-B305CA2B5D44 Q31119950-7A85D882-F17B-415D-B28C-5291A22CD009 Q33318585-D1725BEF-4B3E-438A-9A74-838C41A39C30 Q33508851-8DDE8A9B-BABE-4A52-A8C5-6D95FBDEF501 Q33525351-C7B6B2B6-A514-4207-B55C-13BF0D62A1BD Q33525788-F17EEC1A-B90E-4A5E-B91D-9FAA807A39B0 Q33661574-903DBDA9-1547-4115-8CDE-BA811FA2F2B2 Q33662944-361CCE28-F282-40CA-8ED4-DEB74A85BF21 Q33699436-3FD4DF1B-8C79-4546-80DF-BB1D19515527 Q33711269-93918F2C-102D-4E53-95AD-FB78F31B490A Q33765188-4DC0D891-AC2B-4637-BBEC-6EB1E9A6B0DA Q33833552-25BED849-EF16-4191-8A40-ADFED789B0EC Q33938450-43E9FB8D-B757-42C3-901D-5CBA71DBCA82 Q33965461-FB90F0CB-F5C6-4A0D-B55B-2F91F9F1CAF2 Q33997543-3B70C603-6191-4DEF-9825-0C991063FB93 Q34098617-DC87EA99-2D95-4484-964F-C19AD94FBD57 Q34117195-43A06676-F3B5-465E-9A79-9333E031EC75 Q34375197-FE149D91-0DA4-4D8F-9072-22CA4AD0D872 Q34425354-4B9E84B8-2FFA-47FE-85BB-D8795E1DC4F3 Q34432248-AB199A7D-88B8-4E55-AA55-06A76F210A94 Q34442574-3D1B2C38-5E40-4D3E-B3EF-DD311F5E0911 Q34495265-EB8FC8DC-F90E-4418-8719-BFC486BF6B87

P2860

'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

http://www.wikidata.org/entity/Q49017127

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh-hant

name

'Malignant' middle cerebral ar ...... l course and prognostic signs.

@en

'Malignant' middle cerebral ar ...... l course and prognostic signs.

@nl

type

label

'Malignant' middle cerebral ar ...... l course and prognostic signs.

@en

'Malignant' middle cerebral ar ...... l course and prognostic signs.

@nl

prefLabel

'Malignant' middle cerebral ar ...... l course and prognostic signs.

@en

'Malignant' middle cerebral ar ...... l course and prognostic signs.

@nl

P1433

Q49017127-12249DB0-E087-42F6-B1D4-B89B84134102

P1476

Q49017127-3757744C-A4F8-409F-8929-7EB4BD36747D

P2093

Q49017127-0DF881E6-E4AD-4A95-BA04-B90E1AE41F6F

Q49017127-1A4F4939-8395-47D4-A565-71061E789C0F

Q49017127-40C27D18-B7C4-46A2-AC27-34A62CC795AF

Q49017127-61758FA9-CCB3-40BF-9EC5-DD4982E5A54E

Q49017127-A200CB22-EC15-4E91-B883-6BE4C565EFC9

Q49017127-BEF865EE-8E2A-4525-801E-8BED1EB8653E

P304

Q49017127-CAA8F175-FFA7-44CB-B36E-3BE8785CB399

P31

Q49017127-492C9C3C-87CB-4DEA-94D7-BBD45DC8EF24

P356

Q49017127-34CFDD90-48FC-4234-ACEF-85DE2140BF91

P433

Q49017127-6977B4EB-A51F-4935-98F6-5C3C5BDABF07

P478

Q49017127-6423E0A9-9B9D-4037-B02B-40BD444F69DB

P577

Q49017127-224EBA96-24EC-4F94-9276-75F3A9928DA7

P698

Q49017127-240DC95E-396A-4B85-90AA-3EDFE97A2DFF

P356

ARCHNEUR.1996.00550040037012

P1433

P1476

'Malignant' middle cerebral ar ...... l course and prognostic signs.

@en

P2093

De Georgia M

http://www.w3.org/2001/XMLSchema#string

Hacke W

http://www.w3.org/2001/XMLSchema#string

Horn M

http://www.w3.org/2001/XMLSchema#string

Schwab S

http://www.w3.org/2001/XMLSchema#string

Spranger M

http://www.w3.org/2001/XMLSchema#string

von Kummer R

http://www.w3.org/2001/XMLSchema#string

P304

309-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.1996.00550040037012

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

1996-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8929152

http://www.w3.org/2001/XMLSchema#string